Tickr
Home Explore Daily Brief Market Watchlists Portfolio
Research
Catalysts Signal Factory Screener Market News Event Calendar Valuation Plot Heat Map Top Investors Industry Trends Options
AI Assistant Notifications Account
Enanta Pharmaceuticals, Inc. logo

Enanta Pharmaceuticals, Inc. (ENTA) Stock Ticker

NASDAQ: ENTA · Healthcare · Biotechnology
$11.88-1.00%
USD · as of 2026-09-28 · market cap $345.5M
Open ENTA in TickrDownload for iPhone

ENTA right now

Options expect by Oct 6±8.8%
Options expect by Oct 29±18.1%
Priced in for Nov 16 earnings±23.0%
IV rank (30-day)11% · cheap
From Tickr's live models · 2026-09-29. Not investment advice.

Market factors today

Tickr 500 vs S&P 500+0.49%+1.0% MTD
Momentum L/S+1.35%+15.1% MTD
High-beta momo L/S+1.46%+22.2% MTD
Rate sensitivity L/S+1.91%+6.9% MTD
Oil sensitivity L/S-2.54%-5.3% MTD
Unprofitable tech-1.43%+3.7% MTD

Unlock the full ENTA picture

🔒 Implied move chart & probabilities
🔒 Live options flow
🔒 AI analysis & chat on ENTA
🔒 Catalysts & earnings
🔒 Strategy Lab
🔒 Financials & estimates
Start your 7-day free trial

About Enanta Pharmaceuticals, Inc.

Enanta Pharmaceuticals, Inc. is a biotechnology firm dedicated to discovering and advancing small molecule therapies designed to combat a range of viral infections and various liver conditions. Its research and development efforts are primarily focused on addressing pathogens such as respiratory syncytial virus (RSV), SARS-CoV-2, human metapneumovirus (hMPV), and the hepatitis B virus (HBV). The company also holds a strategic partnership and licensing agreement with Abbott Laboratories. This collaboration involves the joint identification, development, and market introduction of specific HCV NS3 and NS3/4A protease inhibitor compounds, including known agents like paritaprevir and glecaprevir, which are utilized in the management of chronic hepatitis C virus. Founded in 1995, Enanta Pharmaceuticals, Inc. operates from its principal office located in Watertown, Massachusetts.

ENTA stock facts

Ticker symbolENTA
ExchangeNASDAQ Global Select
SectorHealthcare
IndustryBiotechnology
Market cap$345.5M
CEOJay R. Luly
Employees120
HeadquartersWatertown, MA, US
IPO date2013-03-21
Websitewww.enanta.com

What you can see for ENTA on Tickr

Live ENTA price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the ENTA report.

Rankings

Largest Healthcare companiesLargest companies by market cap

FAQ

What is the ticker symbol for Enanta Pharmaceuticals, Inc.?

The ticker symbol for Enanta Pharmaceuticals, Inc. is ENTA, listed on the NASDAQ Global Select.

What is ENTA?

Enanta Pharmaceuticals, Inc. is a biotechnology firm dedicated to discovering and advancing small molecule therapies designed to combat a range of viral infections and various liver conditions. Its research and development efforts are primarily focused on addressing pathogens such as respiratory syncytial virus (RSV), SARS-CoV-2, human metapneumovirus (hMPV), and the hepatitis B virus (HBV). The…

HomeExploreMarketLists
All pages